Mechanism of action of the selective tumor radiosensitizer nicotinamide
- 1 September 1988
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 15 (3), 685-690
- https://doi.org/10.1016/0360-3016(88)90312-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gainInternational Journal of Radiation Oncology*Biology*Physics, 1987
- Preferential tumor radiosensitization by analogs of nicotinamide and benzamideInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Changes in misonidazole binding with hypoxic fraction in mouse tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Current status of treatment of localized disease and future aspectsInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Carcinoma of the cervix—anaemia, radiotherapy and hyperbaric oxygenThe British Journal of Radiology, 1983
- Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gainBritish Journal of Cancer, 1982
- An Evaluation of Niacinamide in the Treatment of Childhood SchizophreniaAmerican Journal of Psychiatry, 1970
- Tissue NAD Levels and the Response to Irradiation or Cytotoxic DrugsBritish Journal of Cancer, 1970
- HIGH-PRESSURE OXYGEN AND RADIOTHERAPYThe Lancet, 1955
- The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in RadiotherapyThe British Journal of Radiology, 1953